Pfiz­er ac­cused of Covid-19 vac­cine patent in­fringe­ment again, this time by Ar­bu­tus and Genevant

Pfiz­er ac­cused of Covid-19 vac­cine patent in­fringe­ment again, this time by Ar­bu­tus and Genevant

Source: 
Endpoints
snippet: 

Arbutus has accused Pfizer and BioNTech of infringing its lipid nanoparticle technology patents in developing their blockbuster mRNA Covid-19 vaccine.